Additional information received indicates that the device is not available for return, therefore no product investigation can be performed, and the customer complaint cannot be confirmed.Manufacturing record evaluation (mre) cannot be conducted because no lot number was provided by the customer.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
|
It was reported that a patient underwent an atrial fibrialation (afib) ¿ persistent ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter and suffered a massive stroke.It was reported that after an afib case, the patient suffered a massive stroke.They reported there were no visible signs on the patient during the procedure.They did not have any details on how the stroke was first discovered and whether any medical intervention had to be provided.They stated they were informed today that after the patient suffered a massive stroke, they were unable to follow commands, unable to speak and failed the swallow test.The patient was admitted to the icu at the time of the call.The ablation catheter is not available to return.The adverse event was discovered post use of biosense webster (bwi) products.The physician¿s opinion on the cause of this adverse event was that it was procedure related.The physician had returned to the left atrium (la) after protamine was administered.The bwi representative talked to the physician afterwards and he felt that it may have been the culprit, despite restarting heparin.The physician did not indicate that bwi products could be possible reason for the adverse event.Outcome of the adverse event was improved, regained some function.In rehab.Patient required extended hospitalization because of the adverse event.Other relevant history- prior af ablation in 2018 with no known complications.Generator information was smartablate / m490002 / g4c-0704.There was no evidence of char during the procedure.There was no evidence of blood thrombus/clot during the procedure.Correct catheter settings were selected on the generator.Pump switching was from "low" to "high" flow during ablation.
|